FF PHARMA
FF Pharma, a biopharmaceutical company, develops anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The functions of CD40 in immune regulation suggest that the CD40 pathway may play a role in diseases in which anomalous immune responses, e.g. autoantibody production or chronic inflammation, are a feature.
FF PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2012-10-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.ffpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4 M EUR
Technology used in webpage:
IPhone / Mobile Compatible SPF Content Delivery Network Amazon Amazon Virginia Region NameBright StatCounter
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Employees Featured
Founder
Investors List
Limburgse Reconversie Maatschappij
Limburgse Reconversie Maatschappij investment in Series A - FF Pharma
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series A - FF Pharma
PMV Pharmaceuticals
PMV Pharmaceuticals investment in Series A - FF Pharma
Official Site Inspections
http://www.ffpharma.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
